{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:46:31Z","timestamp":1790257591896,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangxi medical high-level backbone personnel training\u201c139\u201d Project","award":["20141201 and 201822"],"award-info":[{"award-number":["20141201 and 201822"]}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"crossref","award":["2017GXNSFDA198009"],"award-info":[{"award-number":["2017GXNSFDA198009"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Fund of the 17th Guangxi New Century \u201cTen, Hundred, Thousand\u201d Talent Project","award":["2014210"],"award-info":[{"award-number":["2014210"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81360387"],"award-info":[{"award-number":["81360387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5417-7","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T12:06:01Z","timestamp":1552651561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Caiyun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-4034","authenticated-orcid":false,"given":"Zhijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"issue":"12","key":"5417_CR1","first-page":"834","volume":"42","author":"ZJ Yang","year":"2007","unstructured":"Yang ZJ, Yang G, Jiang YM, Ran YL, Yang ZH, Zhang W, Zhang JQ, Pan ZM, Li L. Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens. Zhonghua Fu Chan Ke Za Zhi. 2007;42(12):834\u20139.","journal-title":"Zhonghua Fu Chan Ke Za Zhi."},{"issue":"2","key":"5417_CR2","first-page":"113","volume":"46","author":"ZJ Yang","year":"2011","unstructured":"Yang ZJ, Yang G, Jiang YM, Ran YL, Yang ZH, Zhang W, Zhang JQ, Pan ZM, Li L. Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA (125) in detecting and monitoring ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 2011;46(2):113\u20138.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"12","key":"5417_CR3","doi-asserted-by":"publisher","first-page":"19274","DOI":"10.18632\/oncotarget.13866","volume":"8","author":"L Xue","year":"2017","unstructured":"Xue L, Yu X, Jiang X, Deng X, Mao L, Guo L, Fan J, Fan Q, Wang L, Lu SH. TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141. Oncotarget. 2017;8(12):19274\u201384.","journal-title":"Oncotarget"},{"issue":"2","key":"5417_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1159\/000445664","volume":"39","author":"J Cao","year":"2016","unstructured":"Cao J, Yang JC, Ramachandran V, Arumugam T, Deng DF, Li ZS, Xu LM, Logsdon CD. TM4SF1 regulates pancreatic Cancer migration and invasion in vitro and in vivo. Cell Physiol Biochem. 2016;39(2):740\u201350.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"5417_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/ijms17050661","volume":"17","author":"YK Huang","year":"2016","unstructured":"Huang YK, Fan XG, Qiu F. TM4SF1 promotes proliferation, invasion, and metastasis in human liver Cancer cells. Int J Mol Sci. 2016;17(5):661.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5417_CR6","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3892\/ijo.2016.3430","volume":"48","author":"YR Park","year":"2016","unstructured":"Park YR, Lee ST, Kim SL, Liu YC, Lee MR, Shin JH, Seo SY, Kim SH, Kim IH, Lee SO, Kim SW. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. Int J Oncol. 2016;48(5):2135\u201343.","journal-title":"Int J Oncol"},{"issue":"6","key":"5417_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1200\/JCO.1990.8.6.1083","volume":"8","author":"GE Goodman","year":"1990","unstructured":"Goodman GE, Hellstr\u00f6m I, Brodzinsky L, Nicaise C, Kulander B, Hummel D, Hellstr\u00f6m KE. Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer. J Clin Oncol. 1990;8(6):1083\u201392.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5417_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/(SICI)1097-0045(19981001)37:2<91::AID-PROS5>3.0.CO;2-O","volume":"37","author":"RT O'Donnell","year":"1998","unstructured":"O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. L6 monoclonal antibody binds prostate cancer. Prostate. 1998;37(2):91\u20137.","journal-title":"Prostate."},{"issue":"11","key":"5417_CR9","first-page":"2357","volume":"55","author":"HP Svensson","year":"1995","unstructured":"Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates. Cancer Res. 1995;55(11):2357\u201365.","journal-title":"Cancer Res"},{"issue":"3B","key":"5417_CR10","first-page":"1735","volume":"17","author":"SJ Denardo","year":"1997","unstructured":"Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. Yttrium-90\/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997;17(3B):1735\u201344.","journal-title":"Anticancer Res"},{"issue":"8","key":"5417_CR11","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/1535-7163.MCT-15-0188","volume":"14","author":"A Visintin","year":"2015","unstructured":"Visintin A, Knowlton K, Tyminski E, Lin CI, Zheng X, Marquette K, Jain S, Tchistiakova L, Li D, O'Donnell CJ, Maderna A, Cao X, Dunn R, Snyder WB, Abraham AK, Leal M, Shetty S, Barry A, Zawel L, Coyle AJ, Dvorak HF, Jaminet SC. Novel anti-TM4SF1 antibody-drug conjugates with activity against tumor cells and tumor vasculature. Mol Cancer Ther. 2015;14(8):1868\u201376.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"5417_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1110\/ps.9.8.1594","volume":"9","author":"MD Wright","year":"2000","unstructured":"Wright MD, Ni J, Rudy GB. The L6 membrane proteins a new four-transmembrane superfamily. Protein Sci. 2000;9(8):1594\u2013600.","journal-title":"Protein Sci"},{"issue":"2","key":"5417_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/excr.2001.5250","volume":"267","author":"J Storim","year":"2001","unstructured":"Storim J, Friedl P, Schaefer BM, Bechtel M, Wallich R, Kramer MD, Reinartz J. Molecular and functional characterization of the four-transmembrane molecule L6 in epidermal keratinocytes. Exp Cell Res. 2001;267(2):233\u201342.","journal-title":"Exp Cell Res"},{"issue":"7","key":"5417_CR14","first-page":"2807","volume":"9","author":"YR Kao","year":"2003","unstructured":"Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW, Roffler SR. Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res. 2003;9(7):2807\u201316.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"5417_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/pros.21340","volume":"71","author":"N Allioli","year":"2011","unstructured":"Allioli N, Vincent S, Vlaeminck-Guillem V, Decaussin-Petrucci M, Ragage F, Ruffion A, Samarut J. TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration. Prostate. 2011;71(11):1239\u201350.","journal-title":"Prostate."},{"issue":"2","key":"5417_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3892\/ijo.2013.2189","volume":"44","author":"L Xu","year":"2014","unstructured":"Xu L, Li Q, Xu D, Wang Q, An Y, Du Q, Zhang J, Zhu Y, Miao Y. Hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol. 2014;44(2):459\u201366.","journal-title":"Int J Oncol"},{"issue":"4","key":"5417_CR17","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1006\/bbrc.2001.6047","volume":"289","author":"M Otsuka","year":"2001","unstructured":"Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Y, Omata M, Seki N. Differential expression of the L- plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun. 2001;289(4):876\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"5417_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471\/2407-11-169","volume":"11","author":"GJ Gordon","year":"2011","unstructured":"Gordon GJ, Bueno R, Sugarbaker DJ. Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro. BMC Cancer. 2011;11:169. \n                    https:\/\/doi.org\/10.1186\/1471\/2407-11-169\n                    \n                  .","journal-title":"BMC Cancer"},{"issue":"2","key":"5417_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.21089","volume":"116","author":"YW Chang","year":"2005","unstructured":"Chang YW, Chen SC, Cheng EC, Ko YP, Lin YC, Kao YR, Tsay YG, Yang PC, Wu CW, Roffler SR. CD13(aminopeptidase N) can associate with tumor-associated antigen l6 and enhance the motility of human lung cancer cells. Int J Cancer. 2005;116(2):243\u201352.","journal-title":"Int J Cancer"},{"issue":"1","key":"5417_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2016.06.009","volume":"166","author":"H Gao","year":"2016","unstructured":"Gao H, Chakraborty G, Zhang Z, Akalay I, Gadiya M, Gao Y, Sinha S, Hu J, Jiang C, Akram M, Brogi E, Leitinger B, Giancotti FG. Multi-organ site metastatic reactivation mediated by non-canonical Discoidin domain receptor 1 signaling. Cell. 2016;166(1):47\u201362.","journal-title":"Cell."},{"issue":"3","key":"5417_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/CJI.0b013e318248f2ae","volume":"35","author":"SH Tu","year":"2012","unstructured":"Tu SH, Huang HI, Lin SI, Liu HY, Sher YP, Chiang SK, Chong P, Roffler S, Tseng GC, Chen HW, Liu SJ. A novel HLA-A2\u2013restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo. J Immunother. 2012;35(3):235\u201344.","journal-title":"J Immunother"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5417-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T20:12:09Z","timestamp":1584130329000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5417-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5417"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5417-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of patients\u2019 tissues and data for the study had obtained written consents from all participates. The study was approved by The Ethics Committee of Affiliated tumor hospital of Guangxi Medical University with the following reference number: NO. LW2018001, and the research were conducted in conformity with the Declaration of Helsinki and the NIH guidelines (NIH Pub. No. 85\u201323, revised 1996) .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"237"}}